dexmedetomidine has been researched along with Brain Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Miao, GS; Song, RX; Wang, R | 1 |
| Jin, X; Li, Z; Pan, D; Shen, R; Wang, H; Wang, Z | 1 |
| Li, J; Mei, B; Zuo, Z | 1 |
| Angert, RM; Cosnahan, AS; Jano, E; Wachtel, EV | 1 |
| Apan, A; Atilla, P; Bakar, B; Kasimcan, O; Kilinc, K; Kose, EA; Muftuoglu, S | 1 |
| Gengyun, S; Houqing, L; Wenjie, W | 1 |
| Enomoto, Y; Fukuoka, N; Iida, H; Yano, H | 1 |
| Akpınar, H; Akpınar, O; Çiğ, B; Nazıroğlu, M; Övey, İS | 1 |
| Han, F; Liu, Z; Ning, Q; Sun, H; Wang, X; Yang, M; Zhang, J; Zhang, R; Zhang, X; Zhao, W | 1 |
| Bronster, D; Nomoto, K; Scurlock, C | 1 |
| Dincer, E; Ozgultekin, A; Turan, C; Turan, G; Yuksel, G | 1 |
1 review(s) available for dexmedetomidine and Brain Diseases
| Article | Year |
|---|---|
Effects of dexmedetomidine on outcomes following craniocerebral operation - a meta-analysis.
Topics: Analgesics, Non-Narcotic; Brain Diseases; Dexmedetomidine; Hemodynamics; Humans; Neurosurgery; Treatment Outcome | 2014 |
1 trial(s) available for dexmedetomidine and Brain Diseases
| Article | Year |
|---|---|
Advantageous effects of dexmedetomidine on haemodynamic and recovery responses during extubation for intracranial surgery.
Topics: Adolescent; Adult; Aged; Anesthesia Recovery Period; Blood Pressure; Brain Diseases; Dexmedetomidine; Female; Heart Rate; Humans; Intubation; Male; Middle Aged; Neurosurgery; Recovery of Function | 2008 |
9 other study(ies) available for dexmedetomidine and Brain Diseases
| Article | Year |
|---|---|
Dexmedetomidine-mediated neuroprotection against sevoflurane-induced brain development abnormality in fetal mice brain.
Topics: Anesthetics; Anesthetics, Inhalation; Animals; Brain; Brain Diseases; Dexmedetomidine; Female; Mice; Neuroprotection; Neuroprotective Agents; Pregnancy; Sevoflurane | 2023 |
The Effects of Dexmedetomidine Post-Conditioning on Cardiac and Neurological Outcomes After Cardiac Arrest and Resuscitation in Swine.
Topics: Animals; Brain Diseases; Cardiopulmonary Resuscitation; Dexmedetomidine; Disease Models, Animal; Heart Arrest; Heart Diseases; Male; Random Allocation; Swine; Treatment Outcome | 2021 |
Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor.
Topics: Animals; Brain Diseases; Dexmedetomidine; Inflammation; Male; Mice; Receptors, Adrenergic; Sepsis | 2021 |
Dexmedetomidine versus intermittent morphine for sedation of neonates with encephalopathy undergoing therapeutic hypothermia.
Topics: Brain Diseases; Cohort Studies; Dexmedetomidine; Humans; Hypothermia, Induced; Infant, Newborn; Morphine | 2021 |
Effects of intracisternal and intravenous dexmedetomidine on ischemia-induced brain injury in rat: a comparative study.
Topics: Adrenergic alpha-Agonists; Animals; Blood Glucose; Blood Pressure; Brain Diseases; Brain Ischemia; Cisterna Magna; Dexmedetomidine; Hippocampus; Injections; Injections, Intravenous; Lipid Peroxidation; Male; Rats; Rats, Wistar | 2013 |
[Monitored Anesthesia Care for Deep Brain Stimulation and Embolization of Brain Arteriovenous Malformation].
Topics: Anesthesia; Brain; Brain Diseases; Deep Brain Stimulation; Dexmedetomidine; Embolization, Therapeutic; Humans; Monitoring, Physiologic | 2015 |
The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of TRPM2 and TRPV1 channels.
Topics: Animals; Apoptosis; Brain Diseases; Calcium; Dexmedetomidine; Ganglia, Spinal; Hippocampus; Male; Neurons; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; TRPM Cation Channels; TRPV Cation Channels | 2016 |
Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Diseases; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Lipopolysaccharides; Male; Malondialdehyde; Mice, Inbred BALB C; Neurodegenerative Diseases; Neuroimmunomodulation; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Reactive Oxygen Species; Sepsis; Tumor Necrosis Factor-alpha | 2017 |
Dexmedetomidine controls twitch-convulsive syndrome in the course of uremic encephalopathy.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged, 80 and over; Aortic Valve Stenosis; Brain Diseases; Delirium; Dexmedetomidine; Heart Valve Prosthesis Implantation; Humans; Male; Renal Dialysis; Renal Insufficiency, Chronic; Seizures; Syndrome; Time Factors; Tremor; Uremia | 2011 |